Journal of Personalized Medicine

Journal of Personalized Medicine is an international, peer-reviewed, open access journal on personalized medicine published monthly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, and many other databases.
  • Journal Rank: JCR - Q1 (Health Care Sciences & Services) / CiteScore - Q2 (Medicine, miscellaneous)
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 19.1 days after submission; acceptance to publication is undertaken in 3.5 days (median values for papers published in this journal in the first half of 2021).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Impact Factor: 4.945 (2020) ; 5-Year Impact Factor: 4.994 (2020)
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Applied Sciences, Biomedicines, Entropy, JPM
eHealth and mHealth: Challenges and Prospects Editor-in-Chief: Anton Civit
Deadline: 31 December 2022
Special Issue in JPM
Predicting Psychopathological Onset: Early Signs of Neuropsychiatric Diseases Guest Editor: Marco Costanzi
Deadline: 10 December 2021
Special Issue in JPM
Lymphoma and Cancer Therapy Guest Editor: Carla Minoia
Deadline: 31 December 2021
Special Issue in JPM
Cancer Biomarker Research and Personalized Medicine Guest Editor: James Meehan
Deadline: 15 January 2022
Topical Collection in JPM
Genomic Medicine and Policy Collection Editors: Christine Lu, Kurt Christensen, Nina Sperber
Topical Collection in JPM
Personalised Medicine–Bringing Innovation to the Healthcare System Collection Editors: Denis Horgan, Gordon McVie
Back to TopTop